Pathogenic features of CD4+CD28- T cells in immune disorders.
about
T-cell aging in rheumatoid arthritisThe story of CD4+ CD28- T cells revisited: solved or still ongoing?An approach to the immunophenotypic features of circulating CD4⁺NKG2D⁺ T cells in invasive cervical carcinoma.Rheumatoid Arthritis, Immunosenescence and the Hallmarks of AgingCytomegalovirus infection exacerbates autoimmune mediated neuroinflammation.Indoxyl sulfate (IS)-mediated immune dysfunction provokes endothelial damage in patients with end-stage renal disease (ESRD).Peripheral and site-specific CD4(+) CD28(null) T cells from rheumatoid arthritis patients show distinct characteristics.Oxidative stress, T cell DNA methylation, and lupus.CD28 expression is required after T cell priming for helper T cell responses and protective immunity to infection.Reduced T-cell repertoire restrictions in abatacept-treated rheumatoid arthritis patients.Characterization of the inflammatory cell infiltrate and expression of costimulatory molecules in chronic echinococcus granulosus infection of the human liverQuantitative and qualitative characterization of expanded CD4+ T cell clones in rheumatoid arthritis patients.A grim picture, indeedReactivation of immune responses against Mycobacterium tuberculosis by boosting with the CpG oligomer in aged mice primarily vaccinated with Mycobacterium bovis BCGThe trajectory of the blood DNA methylome ageing rate is largely set before adulthood: evidence from two longitudinal studies.Unusual CD4+CD28- T Cells and Their Pathogenic Role in Chronic Inflammatory Disorders.Murine Cytomegalovirus Infection Induces Susceptibility to EAE in Resistant BALB/c Mice.The influence of ageing on the development and management of rheumatoid arthritis.Cell surface membrane proteins as personalized biomarkers: where we stand and where we are headed.CD28 Costimulation: From Mechanism to Therapy.Blood cytotoxic/inflammatory mediators in non-eosinophilic asthma.A B Cell-Driven Autoimmune Pathway Leading to Pathological Hallmarks of Progressive Multiple Sclerosis in the Marmoset Experimental Autoimmune Encephalomyelitis Model.Aging of the Immune System. Mechanisms and Therapeutic Targets.Minimal hepatic encephalopathy is associated with expansion and activation of CD4+CD28-, Th22 and Tfh and B lymphocytesGenetic variation at the CD28 locus and its impact on expansion of pro-inflammatory CD28 negative T cells in healthy individuals.ATG-induced accelerated immune senescence: clinical implications in renal transplant recipients.Functionalized liposomes loaded with siRNAs targeting ion channels in effector memory T cells as a potential therapy for autoimmunity.Phenotypic characteristics of aged CD4+ CD28null T lymphocytes are determined by changes in the whole-genome DNA methylation pattern.Cytotoxic CD4+ T Cells Drive Multiple Sclerosis Progression.Metabolic control of the scaffold protein TKS5 in tissue-invasive, proinflammatory T cells.Intestinal recruiting and activation profiles in peripheral blood mononuclear cells in response to pathogen-associated molecular patterns stimulation in patients with IBS.Age-Associated B Cells with Proinflammatory Characteristics Are Expanded in a Proportion of Multiple Sclerosis Patients.Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis.[Clinical consequences of immunosenescence in chronic kidney diseases].Checks and Balances in Autoimmune Vasculitis.Clinical significance of increased peripheral blood CD4(+) CD28(-) T cells of asthmatic children.
P2860
Q26859971-44218380-447E-4F87-BC3B-9C3EC41B0694Q28082856-40CBE1F9-36CD-41C8-9BCD-77FF9B48362CQ30400692-746E12E4-0851-4202-875C-06C0489F2E63Q33555281-F16B9FAE-DA12-45FA-B7DB-1DAC88B55D2EQ33673956-E023DDC7-0F77-4C73-A7D0-85DE4603A667Q33780032-6208FBEC-516D-4F0E-A4DA-C7CB780352A1Q33782717-20970B1C-656C-45C1-902A-3F8BB4F2F346Q34077487-B8F11D3F-A4FF-41AE-B60B-A3EAE49082F1Q34561705-FC9CD22A-A8A8-4288-9F69-55B18037F9ACQ35025444-CFC2BA37-10DC-4195-8FDF-9B34CD71A67CQ35844555-3ABF36BB-DB1A-48FB-8A04-91C66492AC97Q35974666-73197C4C-E6C6-41D8-BBEB-443FCE25A20CQ36629099-832429A2-D68C-4F7C-AB98-DD5D89CE6CACQ36992453-063E0FD4-E161-41B2-9B14-50F0E129A470Q37219666-EE79D0C8-00E9-4DD9-AEBC-084A52C65153Q37541433-ACA7CCD1-8AD2-4C7E-9AA1-92EB73A778C5Q37667382-38A1EFD0-82F6-4945-A8EE-EF8B45EACA8FQ38115131-0D94EEE0-9CBE-40C4-81FB-39FD49FD9388Q38138610-7D9766E8-5089-4417-93F9-7E1D76154381Q38837466-DDBEE4FA-6895-4039-9AF5-F0200D33FB8BQ38920807-E02765EF-E2D8-4B5B-A582-F321CED3FA94Q39458392-D0FC399C-9227-45EE-B966-40228EC72693Q40398975-DC76C2FA-D2B1-4062-A6E7-FD2830F53A75Q41159159-37FBD5B2-4D5C-4053-B2A6-541229B0E10FQ41331832-ED8E9E83-35CA-4B2C-BAD0-C17193C61EB1Q41439288-D7424278-01C8-4330-A56D-2A60DBFF702BQ41889056-B2A42600-3E02-45B3-9F2A-A093481847BFQ42318749-6A7364AC-13C4-4DCF-B8E9-77761AAA2832Q42363220-C761E5E5-C5B2-44B6-ACC6-F2A68A1EE7EEQ46819131-756AC26A-F860-417B-953F-03AE94C328C2Q47797635-35ADEE93-1F33-4A7E-BEA6-10300BCB6301Q47881002-BF197058-8EA0-4661-804C-0FC1EB94F81FQ49693642-CAEA8CFF-84A8-4822-B52E-E305B9F377C9Q50730115-CDAC4750-57F2-4ED8-90E4-E815724C58ACQ51764698-26DDE5D9-7580-4791-B9DB-C8DD5D1CF359Q54790703-347CAB40-F773-41A0-9343-6714AA2323BA
P2860
Pathogenic features of CD4+CD28- T cells in immune disorders.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pathogenic features of CD4+CD28- T cells in immune disorders.
@en
type
label
Pathogenic features of CD4+CD28- T cells in immune disorders.
@en
prefLabel
Pathogenic features of CD4+CD28- T cells in immune disorders.
@en
P1476
Pathogenic features of CD4+CD28- T cells in immune disorders
@en
P2093
Niels Hellings
Silva Markovic-Plese
P304
P356
10.1016/J.MOLMED.2012.06.003
P577
2012-07-10T00:00:00Z